SAN RAFAEL, Calif.


,


April 13, 2022


/PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on

Wednesday, April 27


^th

, at

4:30 p.m. ET

to discuss first quarter 2022 financial results and provide a general business update.

Dial-in Number


U.S. / Canada Dial-in Number: (866) 502-9859

International Dial-in Number: (574) 990-1362

Conference ID: 9770836

Replay Dial-in Number: (855) 859-2056

Replay International Dial-in Number: (404) 537-3406

Conference ID: 9770836

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,

www.biomarin.com

. A replay of the call will be archived on the site for one week following the call.

About BioMarin


BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company’s portfolio consists of seven commercialized products and multiple clinical and preclinical product candidates. For additional information, please visit

www.biomarin.com

. Information on such a website is not incorporated by reference into this press release.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2022-financial-results-conference-call-and-webcast-on-wednesday-april-27-at-430pm-et-301524255.html

SOURCE BioMarin Pharmaceutical Inc.